135 related articles for article (PubMed ID: 9845423)
1. Suppressive effects of antihistaminic and/or anti-PAF agents on passive anaphylactic shock in mice sensitized with allogeneic monoclonal IgE and IgG1 antibodies and hyperimmune serum.
Kimura S; Watanabe A; Takeuchi M; Nagata M; Harada M
Immunol Invest; 1998 Dec; 27(6):379-93. PubMed ID: 9845423
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of drug susceptibility of mouse active anaphylactic shock.
Kimura S; Watanabe A; Nagata M; Niinomi Y; Harada M
Immunol Invest; 1996; 25(5-6):425-34. PubMed ID: 8915680
[TBL] [Abstract][Full Text] [Related]
3. Drug susceptibility of PCA in WBB6F1-W/Wv mice.
Kimura S; Watanabe A; Takeuchi M; Nagata M; Nakamura K; Harada M
Cell Mol Life Sci; 1998 May; 54(5):456-60. PubMed ID: 9645225
[TBL] [Abstract][Full Text] [Related]
4. Differential effect of a PAF antagonist CV-3988 on active and passive anaphylactic shock in various mouse strains.
Arimura A; Harada M
Lipids; 1991 Dec; 26(12):1386-90. PubMed ID: 1819738
[TBL] [Abstract][Full Text] [Related]
5. High susceptibility of cataract Shionogi (CTS) mice to passive anaphylactic shock mediated by allogeneic IgE and IgG1 monoclonal antibodies.
Harada M; Nagata M; Takeuchi M; Makino S; Aburahi S
Immunol Invest; 1991 Jun; 20(3):305-15. PubMed ID: 1874560
[TBL] [Abstract][Full Text] [Related]
6. Age-dependent difference in susceptibility to IgE antibody- and IgG1 antibody-mediated passive anaphylactic shock in the mouse.
Harada M; Nagata M; Takeuchi M; Ohara T; Makino S; Watanabe A
Immunol Invest; 1991; 20(5-6):515-23. PubMed ID: 1791039
[TBL] [Abstract][Full Text] [Related]
7. Production of active and passive anaphylactic shock in the WBB6F1 mouse, a mast cell-deficient strain.
Arimura A; Nagata M; Watanabe A; Nakamura K; Takeuchi M; Harada M
Experientia; 1990 Jul; 46(7):739-42. PubMed ID: 2373200
[TBL] [Abstract][Full Text] [Related]
8. Effect of immunological stimulation on the production of platelet-activating factor by rat peritoneal cells: its relevance to anaphylactic reactions.
Pellon MI; Fernandez-Gallardo S; Gijon MA; Garcia MC; Liu FT; Sanchez Crespo M
Immunopharmacology; 1993; 26(1):73-82. PubMed ID: 8407286
[TBL] [Abstract][Full Text] [Related]
9. Anti-IL-4 antibody inhibits antigen specific IgE response but fails to prevent chicken gamma globulin-induced active systemic anaphylaxis: evidence for the involvement of IgG antibodies.
Lee HK; Lee HH; Park YM; Park HJ; Lee JH; Ha TY
J Korean Med Sci; 1996 Apr; 11(2):111-7. PubMed ID: 8835757
[TBL] [Abstract][Full Text] [Related]
10. Anti-CD44 monoclonal antibody (IM7) induces murine systemic shock mediated by platelet activating factor.
Tanaka Y; Makiyama Y; Mitsui Y
J Autoimmun; 2002 Feb; 18(1):9-15. PubMed ID: 11869042
[TBL] [Abstract][Full Text] [Related]
11. Anti-granulocyte antibody suppression of active and passive anaphylactic shock in WBB6F1-W/Wv mice.
Kimura S; Nagata M; Takeuchi M; Takano K; Harada M
Cell Mol Life Sci; 1997 Aug; 53(8):663-6. PubMed ID: 9351469
[TBL] [Abstract][Full Text] [Related]
12. PAF, rather than histamine, participates in mouse anaphylactic hypotension.
Shibamoto T; Liu W; Cui S; Zhang W; Takano H; Kurata Y
Pharmacology; 2008; 82(2):114-20. PubMed ID: 18583921
[TBL] [Abstract][Full Text] [Related]
13. Active and passive cutaneous anaphylaxis in WBB6F1 mouse, a mast cell-deficient strain.
Arimura A; Nagata M; Takeuchi M; Watanabe A; Nakamura K; Harada M
Immunol Invest; 1990 Jun; 19(3):227-33. PubMed ID: 2365426
[TBL] [Abstract][Full Text] [Related]
14. PAF antagonists do not modify IgE antibody production in mice.
Jancar S; Riffo-Vasquez Y; Ferreira AP; Macedo MS
Braz J Med Biol Res; 1991; 24(6):619-21. PubMed ID: 1823281
[TBL] [Abstract][Full Text] [Related]
15. Concurrent blockade of platelet-activating factor and histamine prevents life-threatening peanut-induced anaphylactic reactions.
Arias K; Baig M; Colangelo M; Chu D; Walker T; Goncharova S; Coyle A; Vadas P; Waserman S; Jordana M
J Allergy Clin Immunol; 2009 Aug; 124(2):307-14, 314.e1-2. PubMed ID: 19409603
[TBL] [Abstract][Full Text] [Related]
16. Decrease in IgE Fc receptor expression on mouse bone marrow-derived mast cells and inhibition of paf-acether formation and of beta-hexosaminidase release by dexamethasone.
Benhamou M; Ninio E; Salem P; Hieblot C; Bessou G; Pitton C; Liu FT; Mencia-Huerta JM
J Immunol; 1986 Feb; 136(4):1385-92. PubMed ID: 2935578
[TBL] [Abstract][Full Text] [Related]
17. Pathways of anaphylaxis in the mouse.
Strait RT; Morris SC; Yang M; Qu XW; Finkelman FD
J Allergy Clin Immunol; 2002 Apr; 109(4):658-68. PubMed ID: 11941316
[TBL] [Abstract][Full Text] [Related]
18. Contribution of thromboxane A2 to the antigen-induced immediate asthmatic response mediated by IgG1 antibody by augmentation of bronchial responsiveness in guinea-pigs.
Arimura A; Asanuma F; Kurosawa A; Harada M
Br J Pharmacol; 1994 Jan; 111(1):339-45. PubMed ID: 7912155
[TBL] [Abstract][Full Text] [Related]
19. Study of the effector mechanism involved in the production of haemorrhagic necrosis of the small intestine in rat passive anaphylaxis.
Pellón MI; Steil AA; Furió V; Sánchez Crespo M
Br J Pharmacol; 1994 Aug; 112(4):1101-8. PubMed ID: 7952870
[TBL] [Abstract][Full Text] [Related]
20. Anaphylactic shock caused by immunoglobulin E sensitization after retreatment with the chimeric anti-interleukin-2 receptor monoclonal antibody basiliximab.
Baudouin V; Crusiaux A; Haddad E; Schandene L; Goldman M; Loirat C; Abramowicz D
Transplantation; 2003 Aug; 76(3):459-63. PubMed ID: 12923429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
